Table 3.
Group | IM Injection |
Challenge
|
% Protection | |
---|---|---|---|---|
Live | Dead | |||
PBS (N= 10) | 100µl x 4 | - | 10 | (0%) |
pBudCE4.1 (N= 10) | 0.25µg/ µl x 4=(100 µg/ µl) | - | 10 | (0%) |
pBudCE4.1-ompA (N= 10) | 0.25µg/ µl x 4=(100 µg/ µl) | 6 | 4 | (60%) |
Group | IM Injection |
Challenge
|
% Protection | |
---|---|---|---|---|
Live | Dead | |||
PBS (N= 10) | 100µl x 4 | - | 10 | (0%) |
pBudCE4.1 (N= 10) | 0.25µg/ µl x 4=(100 µg/ µl) | - | 10 | (0%) |
pBudCE4.1-ompA (N= 10) | 0.25µg/ µl x 4=(100 µg/ µl) | 6 | 4 | (60%) |